Medigus Extends Deal With Sinopharm, Awaits Approval

January 18, 2015 | The Israeli company innovating technology to make invasive gastric surgery procedures less invasive, Medigus, announced that it will extend its contract with Chinese company Sinopharm. Sinopharm, which is owned by the Chinese government, announced that the agreement will be extended because regulatory approval for Medigus’s system has yet to secured. According to the new agreement, adding on an agreement signed two years ago, Sinopharm will be the exclusive distributor in China of Medigus’s Muse system for four years after approval is obtained. Medigus is a publicly traded company on the Tel Aviv Stock Exchange.